These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22875663)

  • 1. Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.
    Haas DM; Quinney SK; Clay JM; Renbarger JL; Hebert MF; Clark S; Umans JG; Caritis SN;
    Am J Perinatol; 2013 Apr; 30(4):275-81. PubMed ID: 22875663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic.
    Haas DM; Quinney SK; McCormick CL; Jones DR; Renbarger JL
    J Matern Fetal Neonatal Med; 2012 Apr; 25(4):419-23. PubMed ID: 21644845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nifedipine slow-release during sustained tocolysis.
    ter Laak MA; Roos C; Touw DJ; van Hattum PR; Kwee A; Lotgering FK; Mol BW; van Pampus MG; Porath MM; Spaanderman ME; van der Post JA; Papatsonis DN; van 't Veer NE
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):84-91. PubMed ID: 25407260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
    Mutagonda RF; Kamuhabwa AAR; Minzi OMS; Massawe SN; Asghar M; Homann MV; Färnert A; Aklillu E
    Malar J; 2017 Jul; 16(1):267. PubMed ID: 28673292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis.
    Silberschmidt AL; Kühn-Velten WN; Juon AM; Zimmermann R; von Mandach U
    BJOG; 2008 Mar; 115(4):480-5. PubMed ID: 18271884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine gastrointestinal therapeutic system (GITS) as an alternative to slow-release for tocolysis--tolerance and pharmacokinetic profile.
    Juon AM; Kühn-Velten WN; Burkhardt T; Krähenmann F; Zimmermann R; von Mandach U
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):27-32. PubMed ID: 18394772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine serum levels in pregnant women undergoing tocolysis with nifedipine.
    Marin TZ; Meier R; Kraehenmann F; Burkhardt T; Zimmermann R
    J Obstet Gynaecol; 2007 Apr; 27(3):260-3. PubMed ID: 17464806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine pharmacokinetics during preterm labor tocolysis.
    Ferguson JE; Schutz T; Pershe R; Stevenson DK; Blaschke T
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1485-90. PubMed ID: 2603904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels.
    Katz DA; Grimm DR; Cassar SC; Gentile MC; Ye X; Rieser MJ; Gordon EF; Polzin JE; Gustavson LE; Driscoll RM; O'dea RF; Williams LA; Bukofzer S
    Clin Pharmacol Ther; 2004 Jun; 75(6):516-28. PubMed ID: 15179406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CYP3A4*1G, CYP3A5*3, POR*28, and ABCB1 C3435T on the pharmacokinetics of nifedipine in healthy Chinese volunteers.
    Wang XF; Yan L; Cao HM; Wei LM; Yang WH; Zhang SJ; Zhang LR
    Int J Clin Pharmacol Ther; 2015 Sep; 53(9):737-45. PubMed ID: 26104034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms.
    Op den Buijsch RA; Christiaans MH; Stolk LM; de Vries JE; Cheung CY; Undre NA; van Hooff JP; van Dieijen-Visser MP; Bekers O
    Fundam Clin Pharmacol; 2007 Aug; 21(4):427-35. PubMed ID: 17635182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.
    Egbelakin A; Ferguson MJ; MacGill EA; Lehmann AS; Topletz AR; Quinney SK; Li L; McCammack KC; Hall SD; Renbarger JL
    Pediatr Blood Cancer; 2011 Mar; 56(3):361-7. PubMed ID: 21225912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients.
    Deininger KM; Vu A; Page RL; Ambardekar AV; Lindenfeld J; Aquilante CL
    Clin Transplant; 2016 Sep; 30(9):1074-81. PubMed ID: 27314545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.
    Chen SY; Li JL; Meng FH; Wang XD; Liu T; Li J; Liu LS; Fu Q; Huang M; Wang CX
    Clin Transplant; 2013; 27(3):E272-81. PubMed ID: 23432535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.
    Trofe-Clark J; Brennan DC; West-Thielke P; Milone MC; Lim MA; Neubauer R; Nigro V; Bloom RD
    Am J Kidney Dis; 2018 Mar; 71(3):315-326. PubMed ID: 29162334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial.
    Nassar AH; Abu-Musa AA; Awwad J; Khalil A; Tabbara J; Usta IM
    Am J Perinatol; 2009 Sep; 26(8):575-81. PubMed ID: 19399705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor.
    Sayin NC; Varol FG; Balkanli-Kaplan P; Sayin M
    J Perinat Med; 2004; 32(3):220-4. PubMed ID: 15188794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases.
    Jin M; Gock SB; Jannetto PJ; Jentzen JM; Wong SH
    J Anal Toxicol; 2005 Oct; 29(7):590-8. PubMed ID: 16419387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine pharmacokinetics and plasma levels in the management of preterm labor.
    Papatsonis DN; Bos JM; van Geijn HP; Lok CA; Dekker GA
    Am J Ther; 2007; 14(4):346-50. PubMed ID: 17667209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.